Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with cystic fibrosis

ALTU-135 was efficacious during the 1-month study period at the dose of 25,000 units of lipase, 25,000 units of protease, and 3750 units of amylase.